Potent therapeutic and prophylactic efficacy of F-PAB in mice infected with human enteroviruses : M. Agoh1),2), T. Mizuno1), Y. Agoh1), N. Satoh1), T. Kurimura2) 1)Central Research Laboratories, Maruishi Pharmaceutical Co., Ltd., Osaka, Japan. 2)Institute for Microbial Disease, Osaka University, Osaka, Japan